Skip to main content

MYLAN SM 25 MYLAN SM 25 Pill - brown & yellow capsule/oblong, 18mm

Pill with imprint MYLAN SM 25 MYLAN SM 25 is Brown & Yellow, Capsule/Oblong and has been identified as Sunitinib Malate 25 mg. It is supplied by Mylan Pharmaceuticals Inc.

Sunitinib is used in the treatment of Renal Cell Carcinoma; Gastrointestinal Stromal Tumor; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN SM 25 MYLAN SM 25

Sunitinib malate 25 mg MYLAN SM 25 MYLAN SM 25

Sunitinib Malate

Imprint
MYLAN SM 25 MYLAN SM 25
Strength
25 mg
Color
Brown & Yellow
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-6679
Inactive Ingredients
silicon dioxide, croscarmellose sodium, gelatin, magnesium stearate, mannitol, sodium lauryl sulfate, titanium dioxide, ferric oxide red, ferric oxide yellow, ammonia, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "MYLAN SM 25 MYLAN SM 25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.